EDTUTC-4 New YorkLog in Sign up

ORKA
Oruka Therapeutics, Inc. Common Stock
stockNASDAQ

At CloseOct 2, 2026 3:59:54 PM EDT

84.48USD+1.307%(+1.09)586,391

Pre-marketOct 5, 2026 8:28:30 AM EDT

84.52USD+0.047%(+0.04)

ORKA News

Day breaks

09:46 PM EDTOruka Therapeutics CEO Klein sells $2.09m in stock ·

Investing.com

07:38 AM EDTOruka Therapeutics stock price target maintained at $120 by H.C. Wainwright ·

Investing.com

01:19 PM EDTOruka falls after updating mid-stage trial data for plaque psoriasis therapy ·

Seeking Alpha

07:00 AM EDTOruka Therapeutics Announces Positive Week 28 Data for ORKA-001 from the Ongoing EVERLAST-A Trial Showing Deepening of Responses Without Additional Dosing ·

GlobeNewswire Inc.

06:01 AM EDTOruka Therapeutics general counsel Paul Quinlan sells $936k in stock ·

Investing.com

06:31 PM EDTOruka Therapeutics SVP Arjun Agarwal sells $51,034 in ORKA stock ·

Investing.com

09:45 AM EDTThese mid-cap stocks have A+ momentum grades and over 100% YTD growth ·

Seeking Alpha

09:01 PM EDTOruka Therapeutics SVP Agarwal sells over $926k in common stock ·

Investing.com

09:01 PM EDTOruka Therapeutics chief medical officer Joana Goncalves sells $734k in shares ·

Investing.com

08:45 PM EDTOruka Therapeutics general counsel Paul Quinlan sells $99,442 in stock ·

Investing.com

08:45 PM EDTOruka Therapeutics CEO Lawrence Klein sells $234,680 in ORKA stock ·

Investing.com

08:15 PM EDTOruka Therapeutics COO Sandler sells $86,713 in common stock ·

Investing.com

04:01 PM EDTOruka Therapeutics Appoints Todd Edwards as Chief Commercial Officer ·

GlobeNewswire Inc.